Chemical Compound

(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid

CAS Registry Number 35121-78-9
返回搜索 申请报价
(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid 结构式
Primary record

(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid

库存
8,945 克
纯度
99.7 %
CAS
35121-78-9

化合物标识与属性

CAS
35121-78-9
PubChem CID
5282411
SMILES
CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/O2)O)O
Canonical SMILES
CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)O[C@H]2C[C@H]1O

名称与同义词

  • epoprostenol
  • prostacyclin
  • prostaglandin I2
  • Vasocyclin
  • Prostaglandin X
  • PGI2
  • Epoprostenolum
  • Flolan
  • Epoprostanol
  • Prostacyclin I2
  • epoprostenolo
  • Prostacycline
  • Prostacyclins
  • ProstaglandinI
  • Veletri
  • VentaProst
  • PolyGlycopleX
  • Cyclo-Prostin
  • Epoprostenol sodium
  • Prostaglandins X
  • Prostaglandin 12
  • Prostaglandin I(2)
  • Epoprosterol sodium
  • Sodium prostacyclin
  • Treprostinil sodium
  • PGI(sub 2)
  • Epoprostenol (TN)
  • Epoprostenol [USAN:INN]
  • 35121-78-9
  • Epoprostenolum [INN-Latin]
  • RefChem:57239
  • DCR9Z582X0
  • KB-IV-24
  • PG-I2
  • PROSTACYCLIN [MI]
  • UNII-DCR9Z582X0
  • Epoprostenol (USAN/INN)
  • EPOPROSTENOL [INN]
  • D0V0IX
  • EPOPROSTENOL [USAN]
  • AC1NR00P
  • ACT-385781A
  • SCHEMBL8041
  • Try-200
  • CHEMBL1139
  • EPOPROSTENOL [VANDF]
  • UNII-4K04IQ1OF4
  • BSPBio_001496
  • C20H31NaO5
  • DTXSID5022988
  • EPOPROSTENOL [MART.]
  • CHEBI:15552
  • BIDD:GT0514
  • EPOPROSTENOL [WHO-DD]
  • C20H32O5.Na
  • KAQKFAOMNZTLHT-OZUDYXHBSA-N
  • DTXCID602988
  • GTPL1915
  • orb1705425
  • Epoprostenol sodium [USAN:BAN]
  • B01AC09
  • C20-H31-Na-O5
  • TRY 200
  • HMS1791K18
  • HMS1989K18
  • HMS3402K18
  • C20H32O5
  • HY-A0126
  • ZINC3813078
  • BRN 1690090
  • EINECS 263-273-7
  • U-53217
  • 8222AH
  • EBC-26696
  • LMFA03010087
  • AKOS040744695
  • C20-H32-O5
  • CID5282411
  • DB01240
  • IDI1_033966
  • SMP2_000227
  • U-53,217
  • NCGC00161285-01
  • NCGC00161285-02
  • NCGC00161285-03
  • J17.550A
  • U 53,217
  • PGX
  • U 53,217A
  • CS-0017443
  • NS00007986
  • U 53217
  • (5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
  • 6,9S-epoxy-11R,15S-dihydoxy-5Z,13E-prostadienoic acid
  • (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
  • 54231-EP2305653A1
  • 54231-EP2308562A2
  • 88471-EP2272832A1
  • 88471-EP2289518A1
  • 88471-EP2292231A1
  • 88471-EP2305260A1
  • 88471-EP2305653A1
  • EN300-21690431
  • Q412050
  • (5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate
  • (5Z)-9-deoxy-6,9-alpha-epoxy-delta-5-PGF1-alpha
  • BRD-K64054020-001-02-7
  • BRD-K64054020-001-03-5
  • (Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-ylidene)pentanoic acid
  • 6,9-alpha-Epoxy-11-alpha,15(S)-dihydroxyprosta-5(Z),13(E)-dien-1-oic acid
  • 63859-31-4
  • Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-
  • N0001-003951
  • (5Z)-5-[(3Ar,4R,5R,6aR)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
  • (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid
  • (Z)-(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valeric acid
  • (5Z,9alpha,11alpha,13E,15S)-11,15-dihydroxy-6,9-epoxyprosta-5,13-dien-1-oic acid
  • Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9alpha,11alpha,13E,15S)-
  • Prosta-5,13-dien-1-oicacid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9a,11a,13E,15S)-
  • 5-[(2Z,3aR,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-hexahydro-2H-cyclopenta[b]furan-2-ylidene]pentanoic acid
  • (5Z,13E,15S)-11beta,15-Dihydroxy-9beta,12alpha-6,9-epoxyprosta-5,13-dien-1-oic acid
  • (5Z,13E,15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oic acid
  • (5Z,9-alpha,11-alpha,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
  • 6,9.alpha.-Epoxy-11.alpha.,15S-dihydroxyprosta-5Z,13E-dien-1-oic acid, monosodium salt
  • Sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate
  • (5E)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3R)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
  • (5Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((E,3S)-3-hydroxyoct-1-enyl)-3,3a,4,5,6,6a-hexahydrocyclopenta(b)furan-2-ylidene)pentanoic acid
  • (5Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((E,3S)-3-hydroxyoct-1-enyl)-3,3a,4,5,6,6a-hexahydrocyclopenta(d)furan-2-ylidene)pentanoic acid
  • (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[d]furan-2-ylidene]pentanoic acid
  • (5Z)-5-[(4R,5R)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
  • (Z)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-((E)-(3S)-3-HYDROXY-1-OCTENYL)-2H-CYCLOPENTA(B)FURAN-.DELTA.(SUP 2,.DELTA.)-VALERATE
  • 1189143-55-2
  • 5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
  • 5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
  • 5-[5-hydroxy-4-(3-hydroxyoct-1-enyl)-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
  • 61849-14-7
  • PROSTA-5,13-DIEN-1-OIC ACID, 6,9-EPOXY-11,15-DIHYDROXY-, (5Z,9.ALPHA.,11.ALPHA.,13E,15S)-
  • Sodium (Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate